{"id":"W2036437506","doi":"10.1016/j.lungcan.2004.06.004","title":"Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Vindesine; Medicine; Cisplatin; Oncology; Mitomycin C; Chemotherapy; Internal medicine; Induction chemotherapy; Lung cancer; Stage (stratigraphy); Surgery; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001584515,0.0002715548,0.0004532852,0.00003961018,0.0002204525,0.00002257436,0.0001015551,0.0001217519,0.0001170497],"category_scores_gemma":[0.00001457637,0.0001724333,0.0001132761,0.000183689,0.00007108334,0.0001341114,0.00003178215,0.0001410515,1.281388e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001470036,"about_ca_system_score_gemma":0.0009428779,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02722903,"about_ca_topic_score_gemma":0.021842,"domain_scores_codex":[0.9985301,0.00002202637,0.0003623181,0.000467929,0.0002713066,0.0003462456],"domain_scores_gemma":[0.9989698,0.00005046316,0.0003012949,0.0003906666,0.0001720387,0.0001157477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6827013,0.01414232,0.0826456,0.007157191,0.005468111,0.00005495452,0.02282315,0.005228897,0.06212258,0.000320687,0.07105949,0.04627574],"study_design_scores_gemma":[0.7112697,0.01100408,0.0168783,0.002978561,0.002167102,0.00001325992,0.0003352281,0.001295562,0.2407425,0.00002153174,0.01270216,0.0005920097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850845,0.006948498,0.000190424,0.002507496,0.0006583651,0.003601926,0.0003033788,0.00002691531,0.0006784775],"genre_scores_gemma":[0.9911172,0.00225721,0.0006050959,0.0003327958,0.0007750783,0.001211945,0.00002927823,0.00005302861,0.003618416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.17862,"threshold_uncertainty_score":0.9960068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01791368138287724,"score_gpt":0.3282780373517002,"score_spread":0.3103643559688229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}